Evidence map›Paper›PMID 41380099›Full record

ArticleBlood advances2026

Real-world evidence of measurable residual disease assessment in multiple myeloma.

Maria-Teresa Cedena, Noemi Puig, Bruno Paiva, José-Enrique de la Puerta, Albert Pérez-Montaña, María Casanova, Joaquín Breña, Antoni García, Felipe de Arriba, Carmen Martínez-Chamorro and 12 more

Abstract read
In one paragraph

Article in Blood advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Maria-Teresa CedenaHematology Department, Hospital Universitario 12 de Octubre, Instituto de Investigación imas12, Madrid, Spain.ORCID 0000-0001-5851-3720
Noemi PuigHematology Department, Hospital Universitario de Salamanca, Instituto de Investigación Biomédica de Salamanca, Salamanca, Spain.ORCID 0000-0001-7535-3861
Bruno PaivaCancer Center Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada, Universidad de Navarra, Instituto de Investigación Sanitaria de Navarra, Pamplona, Spain.ORCID 0000-0003-1977-3815
José-Enrique de la PuertaHematology Department, Hospital Universitario Galdakao, Galdakao, Spain.
Albert Pérez-MontañaHematology Department, Hospital Universitario Son Espases, Palma, Spain.
María CasanovaHematology Department, Hospital Universitario Costa del Sol, Marbella, Spain.ORCID 0000-0003-0784-7688
Joaquín BreñaHematology Department, Hospital Universitario Nuestra Señora de la Candelaria, Santa Cruz Tenerife, Spain.
Antoni GarcíaHematology Department, Hospital Universitario Arnau Vilanova, Lleida, Spain.ORCID 0000-0003-0006-4162
Felipe de ArribaServicio de Hematología. Hospital Universitario Morales Meseguer, IMIB-Pascual Parrilla, Universidad de Murcia, Murcia, Spain.ORCID 0000-0002-4451-1318
Carmen Martínez-ChamorroHematology Department, Hospital Universitario Quirónsalud, Madrid and Universidad Europea de Madrid, Madrid, Spain.
Maialen SirventHematology Department, Hospital Universitario Donostia, Donostia, Spain.
Maria-Jesús BlanchardHematology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain.
Rafael AlonsoHematology Department, Hospital Universitario 12 de Octubre, Instituto de Investigación imas12, Madrid, Spain.ORCID 0000-0003-3774-118X
Miguel-Ángel ÁlvarezHematology Department, Hospital Universitario Reina Sofía, Córdoba, Spain.ORCID 0000-0002-8025-5112
Francisco-Javier CapoteHematology Department, Hospital Universitario Puerta del Mar, Cádiz, Spain.
Ricarda García-SánchezHematology Department, Hospital Universitario Virgen de la Victoria, Málaga, Spain.
José-Juan PérezHematology Department, Hospital Universitario de Salamanca, Instituto de Investigación Biomédica de Salamanca, Salamanca, Spain.
Paula Rodriguez-OteroCancer Center Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada, Universidad de Navarra, Instituto de Investigación Sanitaria de Navarra, Pamplona, Spain.ORCID 0000-0001-5236-7785
Juan-José LahuertaHematology Department, Hospital Universitario 12 de Octubre, Instituto de Investigación imas12, Madrid, Spain.ORCID 0000-0002-3393-9570
Joaquín Martínez-LópezHematology Department, Hospital Universitario 12 de Octubre, Instituto de Investigación imas12, Madrid, Spain.ORCID 0000-0001-7908-0063
Maria-Victoria MateosCancer Center Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada, Universidad de Navarra, Instituto de Investigación Sanitaria de Navarra, Pamplona, Spain.ORCID 0000-0003-2390-1218
Jesús San-MiguelHematology Department, Hospital Universitario de Salamanca, Instituto de Investigación Biomédica de Salamanca, Salamanca, Spain.ORCID 0000-0002-9183-4857

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41380099
PMCPMC12954299

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.